The Role of Phosphodiesterase Inhibitors in Incretin Secretion

NCT02363335 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

NIH

Sponsor class

Conditions

Healthy Volunteers

Interventions

OTHER: Placebo
OTHER: Roflumilast/Sitagliptin
OTHER: Sitagliptin
OTHER: Roflumilast

Sponsor

National Institute on Aging (NIA)